The story so far
Research is vital to help us improve lives for people affected by sarcoma. Since we awarded our very first grants in 2009, Sarcoma UK has funded 98 research projects, investing a total of more than £8 million.
Our priority is to fund research that has the greatest impact for people affected by sarcoma. We continually gather perspectives from people with sarcoma, family members, carers and leading researchers about priority areas we should invest in.
From understanding why people become resistant to chemotherapy drugs, identifying new targets for treatments and finding ways to make sarcoma cells more vulnerable to treatment, our funded research has hugely advanced our understanding of sarcoma. It has contributed to making diagnosis more effective and developed initiatives to improve quality of life.
Your funds and support are helping to produce results which will improve the lives of people affected by sarcoma. We’ve achieved an incredible amount in 10 years, but there’s much more to be done – donate today to support our research programme.
Explore the pages below to learn more about specific research projects and the outcomes they’ve achieved thanks to your donations.
Finding new and better treatments:
Cancer treatment is steadily moving away from a one-size-fits-all approach and focusing on personalised and more targeted treatments, and we are funding research to ensure sarcoma treatment advances in this way.
Understanding sarcoma:
Understanding the underlying causes of sarcoma is essential due to the complexity and rarity of this cancer. It lays the foundation for developing better prevention strategies and more effective treatments.
Improving quality of life:
Improving the quality of life for sarcoma patients is a critical focus of current research, as this rare type of cancer often brings significant physical and emotional challenges. Researchers are working with patients to learn about their experiences and explore various ways to enhance the overall well-being of patients during and after treatment.
Improving Diagnosis:
Due to their rarity and diverse forms, sarcomas are often misdiagnosed or diagnosed late, leading to poorer outcomes for patients. Improved diagnostic tools can enable healthcare providers to detect sarcomas at earlier stages, when treatment is generally more effective and less invasive.
